冷冻象鼻支架植入术与胸主动脉腔内修复术后管腔内血栓形成的危险因素、发生率及临床影响 (TRACE)
FRozen ElephAnt Trunk (FET) 手术与胸主动脉腔内修复术 (TEVAR) 后管腔内血栓形成的危险因素、发生率及临床影响:一项多中心回顾性队列研究
Intraluminal thrombosis (ILT) is a significant but underexplored complication in aortic interventions. It is defined as the formation of thrombosis, partially or totally obstructing the lumen, in the surgically treated, stented, or native aorta. In cases of Frozen Elephant Trunk interventions for which are performed regulary for type A dissections, or pathologies such as penetrating aorting ulcers or aneurysm of the distal arch or proximal descending, an ILT can occur early in the postoperative traject and have severe consequences. A recent systematic review and meta-analysis from our group (abstract attached as Annex 1; manuscript pending) analyzed data from 825 patients. and estimated a pooled incidence of ILT of 8.6% [95% CI: 5.7-12.9]. The included studies reported ILT rates ranging from 6.2% to 16.8% (1-4). Patients with ILT had significantly higher risks of dialysis (43% vs. 16%) and mortality (25% vs. 8%). Risk factors included female gender, older age, and concomitant aortic valve replacement. Despite these findings, the underlying pathophysiology and management strategies for ILT in FET remain poorly defined Intraluminal thrombosis (ILT) is a recognized but poorly studied complication following endovascular thoracic aortic repair (TEVAR). Case reports have described its occurrence, particularly in patients with blunt aortic trauma (5-14), and one study suggested a higher risk of intraluminal narrowing among female patients, associated with increased reoperation rates (15). However, no reliable data exist regarding the overall incidence, risk factors, or clinical outcomes of ILT following TEVAR.
A recent systematic review conducted by our group (abstract attached as Annex 2; manuscript pending) identified 10 case reports and three retrospective studies reporting highly variable ILT rates (5-14, 16-18). A study, focusing on blunt aortic trauma patients, found an ILT incidence of 20.6% in a cohort of 34 patients, while another study observed 2 cases in 97 patients (2.06%), and a third study reported 0 cases in 11 patients (0%). The lack of consistent epidemiological data highlights the necessity of a multicenter cohort study to establish a reliable incidence estimate and investigate potential risk factors and clinical outcomes.
This study aims to fill the knowledge gap through a multicenter analysis involving patients treated with FET and TEVAR. By identifying risk factors for ILT, describing related outcomes, and evaluating management strategies, the ultimate goal is to improve clinical care and outcomes for patients undergoing these procedures.
研究概览
地位
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Milan、意大利、20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adult patients undergoing elective and emergency FET and TEVAR procedures between Jan 2010 and June 2025.
描述
Inclusion Criteria:
- age ≥18 years
- males and females
- presence of pre- and post-operative CT imaging
Exclusion Criteria:
- Patients previously treated with TEVAR or FET
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:RETROSPECTIVE
队列和干预
团体/队列 |
|---|
|
TEVAR WITH ILT
PATIENTS TREATED WITH TEVAR THAT SHOW AN ILT AT FOLLOW UP |
|
FET WITH ILT
PATIENTS TREATED WITH TEVAR THAT SHOW AN ILT AT FOLLOW UP |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
接受FET或TEVAR手术患者术后ILT的发生率(占总病例的百分比)
大体时间:术后长达15年
|
术后长达15年
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.